Adherence in Adolescents and Children Treated on Quetiapine

AstraZeneca

Status: Completed

Conditions: Psychosis

Study type: Observational

Funder types: Industry

Identifiers

NCT00680888

NIS-NES-SER-2006/1

Details and patient eligibility

About

Observational study aimed to describe the adherence in a population of adolescents and children treated on quetiapine from a first psychotic episode whose more important secondary objective is to identify possible predictive factors influencing the adherence to treatment with Quetiapine

Enrollment: 30 patients

Sex: All

Ages: 7 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least one psychotic symptom (delusions or hallucinations) before age 18.
• Start of treatment in a maximum period of 2 years after the onset of first psychotic symptom
• Written informed consent by parents or guardians and patients.

Exclusion criteria

• Pregnancy or lactancy
• High risk of aggression or suicidal behaviour
• Alcohol dependence

Trial design

30 participants in 1 patient group

1

Description:

Children and adolescents with psychosis in outpatients setting on treatment with quetiapine started from january 2003 to june 2006